Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic. If you had come across the ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

No signal for an increase in suicidal ideation or attempts associated with GLP-1 use was seen across subgroups stratified by ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

The future of the weight loss market might not revolve around GLP-1 drugs.

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

This is just a sneak peek at the thousands of consumer insights available to CivicScience clients. Discover more data. The ...

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise ...